# Bivalirudin in Late PCI for Oatients With STEMI

> **NCT04185077** · PHASE4 · UNKNOWN · sponsor: **Second Xiangya Hospital of Central South University** · enrollment: 1200 (estimated)

## Conditions studied

- STEMI - ST Elevation Myocardial Infarction

## Interventions

- **DRUG:** Bivalirudin
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT04185077
- **Lead sponsor:** Second Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-30
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2019-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04185077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04185077, "Bivalirudin in Late PCI for Oatients With STEMI". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04185077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*